ANGELA MEADORS: Open Payments
NPI 1265401640 · POWELL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 13 payments from 7 companies in 2025. Trend: 2023 $118 · 2024 $333 · 2025 $236
Food & beverage: $230Education: $6
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $78 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| AKEBIA THERAPEUTICS INC | 1 | $27 |
| Ardelyx, Inc. | 1 | $25 |
| Travere Therapeutics, Inc. | 4 | $24 |
| Calliditas Therapeutics US Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: COBENFY, FARXIGA, Vafseo, IBSRELA, TARPEYO, JARDIANCE, Filspari.
Industry payments across TN — which companies pay providers there.
